Serveur d'exploration sur le Covid à Stanford

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.

Identifieur interne : 000487 ( Main/Exploration ); précédent : 000486; suivant : 000488

It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.

Auteurs : Alexander W. Kay [États-Unis] ; Tara E. Ness [États-Unis] ; Leonardo Martinez [États-Unis] ; Anna M. Mandalakas [États-Unis]

Source :

RBID : pubmed:32876009

Descripteurs français

English descriptors


DOI: 10.4269/ajtmh.20-1089
PubMed: 32876009
PubMed Central: PMC7543805


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.</title>
<author>
<name sortKey="Kay, Alexander W" sort="Kay, Alexander W" uniqKey="Kay A" first="Alexander W" last="Kay">Alexander W. Kay</name>
<affiliation wicri:level="2">
<nlm:affiliation>Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor College of Medicine and Texas Children's Hospital, Houston</wicri:cityArea>
</affiliation>
<affiliation>
<nlm:affiliation>Baylor College of Medicine Children's Foundation Eswatini, Mbabane, Eswatini.</nlm:affiliation>
<wicri:noCountry code="subField">Eswatini</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Ness, Tara E" sort="Ness, Tara E" uniqKey="Ness T" first="Tara E" last="Ness">Tara E. Ness</name>
<affiliation wicri:level="2">
<nlm:affiliation>Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor College of Medicine and Texas Children's Hospital, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Martinez, Leonardo" sort="Martinez, Leonardo" uniqKey="Martinez L" first="Leonardo" last="Martinez">Leonardo Martinez</name>
<affiliation wicri:level="2">
<nlm:affiliation>Stanford University, Stanford, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Stanford University, Stanford</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Mandalakas, Anna M" sort="Mandalakas, Anna M" uniqKey="Mandalakas A" first="Anna M" last="Mandalakas">Anna M. Mandalakas</name>
<affiliation wicri:level="2">
<nlm:affiliation>Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor College of Medicine and Texas Children's Hospital, Houston</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32876009</idno>
<idno type="pmid">32876009</idno>
<idno type="doi">10.4269/ajtmh.20-1089</idno>
<idno type="pmc">PMC7543805</idno>
<idno type="wicri:Area/Main/Corpus">000357</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000357</idno>
<idno type="wicri:Area/Main/Curation">000357</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000357</idno>
<idno type="wicri:Area/Main/Exploration">000357</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.</title>
<author>
<name sortKey="Kay, Alexander W" sort="Kay, Alexander W" uniqKey="Kay A" first="Alexander W" last="Kay">Alexander W. Kay</name>
<affiliation wicri:level="2">
<nlm:affiliation>Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor College of Medicine and Texas Children's Hospital, Houston</wicri:cityArea>
</affiliation>
<affiliation>
<nlm:affiliation>Baylor College of Medicine Children's Foundation Eswatini, Mbabane, Eswatini.</nlm:affiliation>
<wicri:noCountry code="subField">Eswatini</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Ness, Tara E" sort="Ness, Tara E" uniqKey="Ness T" first="Tara E" last="Ness">Tara E. Ness</name>
<affiliation wicri:level="2">
<nlm:affiliation>Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor College of Medicine and Texas Children's Hospital, Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Martinez, Leonardo" sort="Martinez, Leonardo" uniqKey="Martinez L" first="Leonardo" last="Martinez">Leonardo Martinez</name>
<affiliation wicri:level="2">
<nlm:affiliation>Stanford University, Stanford, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Stanford University, Stanford</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Mandalakas, Anna M" sort="Mandalakas, Anna M" uniqKey="Mandalakas A" first="Anna M" last="Mandalakas">Anna M. Mandalakas</name>
<affiliation wicri:level="2">
<nlm:affiliation>Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Baylor College of Medicine and Texas Children's Hospital, Houston</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The American journal of tropical medicine and hygiene</title>
<idno type="eISSN">1476-1645</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adenosine Monophosphate (analogs & derivatives)</term>
<term>Adenosine Monophosphate (therapeutic use)</term>
<term>Alanine (analogs & derivatives)</term>
<term>Alanine (therapeutic use)</term>
<term>Antitubercular Agents (therapeutic use)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>COVID-19 (MeSH)</term>
<term>Coinfection (MeSH)</term>
<term>Comorbidity (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (mortality)</term>
<term>Coronavirus Infections (virology)</term>
<term>Drug Interactions (MeSH)</term>
<term>HIV Infections (drug therapy)</term>
<term>HIV Infections (epidemiology)</term>
<term>HIV Infections (mortality)</term>
<term>HIV Infections (virology)</term>
<term>HIV-1 (pathogenicity)</term>
<term>Humans (MeSH)</term>
<term>Mycobacterium tuberculosis (pathogenicity)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (mortality)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Prevalence (MeSH)</term>
<term>Rifampin (therapeutic use)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Survival Analysis (MeSH)</term>
<term>Tuberculosis, Pulmonary (drug therapy)</term>
<term>Tuberculosis, Pulmonary (epidemiology)</term>
<term>Tuberculosis, Pulmonary (mortality)</term>
<term>Tuberculosis, Pulmonary (virology)</term>
<term>United States (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>AMP (analogues et dérivés)</term>
<term>AMP (usage thérapeutique)</term>
<term>Alanine (analogues et dérivés)</term>
<term>Alanine (usage thérapeutique)</term>
<term>Analyse de survie (MeSH)</term>
<term>Antituberculeux (usage thérapeutique)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Betacoronavirus (pathogénicité)</term>
<term>Co-infection (MeSH)</term>
<term>Comorbidité (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à VIH (mortalité)</term>
<term>Infections à VIH (traitement médicamenteux)</term>
<term>Infections à VIH (virologie)</term>
<term>Infections à VIH (épidémiologie)</term>
<term>Infections à coronavirus (mortalité)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Interactions médicamenteuses (MeSH)</term>
<term>Mycobacterium tuberculosis (pathogénicité)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (mortalité)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Prévalence (MeSH)</term>
<term>Rifampicine (usage thérapeutique)</term>
<term>Tuberculose pulmonaire (mortalité)</term>
<term>Tuberculose pulmonaire (traitement médicamenteux)</term>
<term>Tuberculose pulmonaire (virologie)</term>
<term>Tuberculose pulmonaire (épidémiologie)</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (pathogénicité)</term>
<term>États-Unis (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Adenosine Monophosphate</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Adenosine Monophosphate</term>
<term>Alanine</term>
<term>Antitubercular Agents</term>
<term>Antiviral Agents</term>
<term>Rifampin</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>AMP</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>HIV Infections</term>
<term>Pneumonia, Viral</term>
<term>Tuberculosis, Pulmonary</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>HIV Infections</term>
<term>Pneumonia, Viral</term>
<term>Tuberculosis, Pulmonary</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Coronavirus Infections</term>
<term>HIV Infections</term>
<term>Pneumonia, Viral</term>
<term>Tuberculosis, Pulmonary</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Infections à VIH</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Tuberculose pulmonaire</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Betacoronavirus</term>
<term>HIV-1</term>
<term>Mycobacterium tuberculosis</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Betacoronavirus</term>
<term>Mycobacterium tuberculosis</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à VIH</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Tuberculose pulmonaire</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>AMP</term>
<term>Alanine</term>
<term>Antituberculeux</term>
<term>Antiviraux</term>
<term>Rifampicine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à VIH</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Tuberculose pulmonaire</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>HIV Infections</term>
<term>Pneumonia, Viral</term>
<term>Tuberculosis, Pulmonary</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Infections à VIH</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Tuberculose pulmonaire</term>
<term>États-Unis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>COVID-19</term>
<term>Coinfection</term>
<term>Comorbidity</term>
<term>Drug Interactions</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Prevalence</term>
<term>SARS-CoV-2</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Analyse de survie</term>
<term>Co-infection</term>
<term>Comorbidité</term>
<term>Humains</term>
<term>Interactions médicamenteuses</term>
<term>Pandémies</term>
<term>Prévalence</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32876009</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1476-1645</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>103</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2020</Year>
<Month>10</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of tropical medicine and hygiene</Title>
<ISOAbbreviation>Am J Trop Med Hyg</ISOAbbreviation>
</Journal>
<ArticleTitle>It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.</ArticleTitle>
<Pagination>
<MedlinePgn>1348-1349</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4269/ajtmh.20-1089</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kay</LastName>
<ForeName>Alexander W</ForeName>
<Initials>AW</Initials>
<AffiliationInfo>
<Affiliation>Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Baylor College of Medicine Children's Foundation Eswatini, Mbabane, Eswatini.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ness</LastName>
<ForeName>Tara E</ForeName>
<Initials>TE</Initials>
<AffiliationInfo>
<Affiliation>Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martinez</LastName>
<ForeName>Leonardo</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Stanford University, Stanford, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mandalakas</LastName>
<ForeName>Anna M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo>
<Affiliation>Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Trop Med Hyg</MedlineTA>
<NlmUniqueID>0370507</NlmUniqueID>
<ISSNLinking>0002-9637</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3QKI37EEHE</RegistryNumber>
<NameOfSubstance UI="C000606551">remdesivir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>415SHH325A</RegistryNumber>
<NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>OF5P57N2ZX</RegistryNumber>
<NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>VJT6J7R4TR</RegistryNumber>
<NameOfSubstance UI="D012293">Rifampin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012293" MajorTopicYN="N">Rifampin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014397" MajorTopicYN="N">Tuberculosis, Pulmonary</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>9</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>10</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>9</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32876009</ArticleId>
<ArticleId IdType="doi">10.4269/ajtmh.20-1089</ArticleId>
<ArticleId IdType="pmc">PMC7543805</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Med Virol. 2020 Oct;92(10):1777-1778</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32293709</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS Patient Care STDS. 2020 Jun;34(6):247-248</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32407127</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2017 Aug 1;12(8):e0182185</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28763500</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet HIV. 2020 Aug;7(8):e554-e564</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32473657</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Nov 19;71(16):2294-2297</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32472138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Nov 19;71(16):2276-2278</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32407467</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 Aug;584(7821):430-436</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32640463</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Glob Health. 2020 Sep;8(9):e1132-e1141</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32673577</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2020 Sep;8(9):844-846</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32758439</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2020 Jun;8(6):536-538</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32220280</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2020 Oct;26(10):2506-2508</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32672531</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pulmonology. 2020 Jul - Aug;26(4):233-240</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32411943</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
<li>Texas</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Kay, Alexander W" sort="Kay, Alexander W" uniqKey="Kay A" first="Alexander W" last="Kay">Alexander W. Kay</name>
</region>
<name sortKey="Mandalakas, Anna M" sort="Mandalakas, Anna M" uniqKey="Mandalakas A" first="Anna M" last="Mandalakas">Anna M. Mandalakas</name>
<name sortKey="Martinez, Leonardo" sort="Martinez, Leonardo" uniqKey="Martinez L" first="Leonardo" last="Martinez">Leonardo Martinez</name>
<name sortKey="Ness, Tara E" sort="Ness, Tara E" uniqKey="Ness T" first="Tara E" last="Ness">Tara E. Ness</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000487 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000487 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidStanfordV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32876009
   |texte=   It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32876009" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidStanfordV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Tue Feb 2 21:24:25 2021. Site generation: Tue Feb 2 21:26:08 2021